Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
about
Carbapenems: past, present, and futureThree decades of beta-lactamase inhibitorsNovel Insights into the Mode of Inhibition of Class A SHV-1 -Lactamases Revealed by Boronic Acid Transition State InhibitorsStructures of the Class D Carbapenemases OXA-23 and OXA-146: Mechanistic Basis of Activity against Carbapenems, Extended-Spectrum Cephalosporins, and AztreonamEnhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem.Non-classical transpeptidases yield insight into new antibacterialsExploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.The enzymes of β-lactam biosynthesis.Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.Effect of asparagine substitutions in the YXN loop of a class C β-lactamase of Acinetobacter baumannii on substrate and inhibitor kinetics.Extended-spectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime.ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides.The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistanceA kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsAminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors.Fragment-based inhibitor discovery against β-lactamaseClinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.Structure of a highly acidic β-lactamase from the moderate halophile Chromohalobacter sp. 560 and the discovery of a Cs(+)-selective binding site.Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.
P2860
Q24634999-619E3B5E-D57A-488E-9D71-3B46E02890A5Q24646623-FABC36AC-BC4B-4932-84E0-EAAD38326998Q27665516-06E3336F-CB67-42F2-9978-C65F706E4F73Q27679174-EE5957D0-EFD1-45C3-991E-26532561208FQ33601560-672F8F12-7E07-4E93-A436-C8A00E041315Q33622976-0336FC37-6ECD-45CE-954C-44B3080C8771Q33730985-898B416E-30B2-44CC-A467-4CADD668C2D8Q33814192-74CD141B-DF44-4CA6-9689-18BC077014B1Q33893632-1DC5BEC6-9AE3-44B2-9994-38B288C0C429Q34310470-4F108A75-3B46-4B33-974B-1EB962CB7AEFQ34680304-26127C93-AE80-4F21-A631-B5947E52A64FQ35014136-95E6FC82-AA36-4647-900D-4ED6CD2EC2ABQ35076850-2138B607-EE35-46F0-A286-E07DCE7E5891Q35270789-AA056AAD-2BF6-4CF4-912B-0EC8B7F7F5CAQ35371319-759AD4C0-6DE5-41CE-BF7A-002B178BEDA1Q35905605-2DFBFECC-5ACB-4FD5-B02F-485B0B61A0EEQ36569183-6A1FD7BF-986C-47D6-967E-220AD0874A34Q37411475-04EF6AA8-A4E7-4B98-A289-98EA020D5864Q37579796-A70D1135-88DC-43E7-A272-802ED5B2B236Q37856761-4471FABD-86A5-4B70-9470-DDA2DBBEEAC9Q38196443-3CE22A8B-AEAF-4233-BD33-AD2AF25CE46CQ39749477-1CC5EF3E-1F00-4351-93E4-8DC6E4D7B32CQ41908473-270FFA9F-E0A2-4FB6-8FD3-484A3633B4E0Q47706889-46439BC6-1530-40E0-8DCC-57BFC298B84E
P2860
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of the class C beta ...... to effective inhibitor design.
@ast
Inhibition of the class C beta ...... to effective inhibitor design.
@en
type
label
Inhibition of the class C beta ...... to effective inhibitor design.
@ast
Inhibition of the class C beta ...... to effective inhibitor design.
@en
prefLabel
Inhibition of the class C beta ...... to effective inhibitor design.
@ast
Inhibition of the class C beta ...... to effective inhibitor design.
@en
P2093
P2860
P50
P356
P1433
P1476
Inhibition of the class C beta ...... to effective inhibitor design.
@en
P2093
Anne M Distler
Christopher R Bethel
Claudia Ori
Magda Taracila
Maja Babic
Sarah M Drawz
P2860
P304
P356
10.1021/BI9015988
P407
P577
2010-01-01T00:00:00Z